U.S. FDA Approves HYRNUO® (sevabertinib) for Previously Treated Patients with HER2-Mutated Locally Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer

Detailed price information for Bayer Aktienges ADR (BAYRY) from The Globe and Mail including charting and trades.
Nature

Reaction mechanisms articles from across Nature Portfolio

Vinyl carbocations have a long history in chemistry, but they have received less attention compared to the more common sp 2-hybridized trivalent carbocations and synthetic applications of these ...

Lilly to highlight progress across key programs in early and advanced hormone receptor-positive breast cancer at the 2025 San Antonio Breast Cancer Symposium

Eli Lilly and Company (NYSE: LLY) today announced that new data from across its breast oncology portfolio and pipeline will ...
MedPage Today

Ultra-Rare Mitochondrial Disease Gets First FDA-Approved Drug

The FDA approved doxecitine and doxribtimine powder (Kygevvi) for thymidine kinase 2 deficiency (TK2d), an ultra-rare mitochondrial depletion syndrome, the agency announced on Monday. A pair of ...